Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$341M |
| 2 |
Automatic Data Processing
ADP
|
+$325M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$248M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$195M |
| 5 |
Comcast
CMCSA
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.83B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.41B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$435M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$256M |
| 5 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$221M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.66% |
| 2 | Technology | 4.22% |
| 3 | Healthcare | 2.96% |
| 4 | Consumer Discretionary | 2.91% |
| 5 | Industrials | 2.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Tenet Healthcare
THC
$21.8B
| $2.22M | ﹤0.01% |
146,191
+145,394
| +18,243% | +$2.05M |
|
|
ARRY
2552
DELISTED
Array Biopharma Inc
ARRY
| $2.21M | ﹤0.01% |
172,942
+66,236
| +62% | +$753K |
|
|
CAVM
2553
CALL
DELISTED
Cavium, Inc.
CAVM
| $2.21M | ﹤0.01% |
26,400
+22,600
| +595% | +$1.75M |
|
|
BGC
2554
DELISTED
General Cable Corporation
BGC
| $2.21M | ﹤0.01% |
74,737
-108,733
| -59% | -$2.57M |
|
|
ERF
2555
PUT
DELISTED
Enerplus Corporation
ERF
| $2.21M | ﹤0.01% |
225,000
+148,100
| +193% | +$1.35M |
|
2556
Hudbay
HBM
$10.1B
| $2.21M | ﹤0.01% |
248,439
-6,336
| -2% | -$49.4K |
|
2557
Pebblebrook Hotel Trust
PEB
$2.12B
| $2.21M | ﹤0.01% |
59,344
+2,105
| +4% | +$77.8K |
|
2558
Hilton Worldwide
HLT
$72.5B
| $2.2M | ﹤0.01% |
27,549
+11,173
| +68% | +$829K |
|
2559
Acadia Pharmaceuticals
ACAD
$4.55B
| $2.2M | ﹤0.01% |
73,031
+26,626
| +57% | +$851K |
|
|
DOC
2560
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $2.2M | ﹤0.01% |
122,164
-165,445
| -58% | -$2.97M |
|
2561
Emergent Biosolutions
EBS
$375M
| $2.2M | ﹤0.01% |
47,274
-6,502
| -12% | -$274K |
|
|
CEQP
2562
DELISTED
Crestwood Equity Partners LP
CEQP
| $2.19M | ﹤0.01% |
84,969
-74,334
| -47% | -$1.81M |
|
|
XLRN
2563
DELISTED
Acceleron Pharma
XLRN
| $2.19M | ﹤0.01% |
51,637
-806,656
| -94% | -$30.3M |
|
|
QVCGA
2564
DELISTED
QVC Group Inc Series A
QVCGA
| $2.19M | ﹤0.01% |
1,848
-124
| -6% | -$144K |
|
|
CHL
2565
CALL
DELISTED
China Mobile Limited
CHL
| $2.19M | ﹤0.01% |
43,300
+16,100
| +59% | +$810K |
|
2566
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.4B
| $2.18M | ﹤0.01% |
33,835
+2,643
| +8% | +$166K |
|
|
WWE
2567
DELISTED
World Wrestling Entertainment
WWE
| $2.18M | ﹤0.01% |
71,360
+59,967
| +526% | +$1.62M |
|
2568
LPL Financial
LPLA
$27.1B
| $2.18M | ﹤0.01% |
38,156
+3,784
| +11% | +$199K |
|
2569
DigitalBridge
DBRG
$2.93B
| $2.18M | ﹤0.01% |
47,745
-6,167
| -11% | -$303K |
|
|
FBC
2570
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $2.18M | ﹤0.01% |
58,141
-786
| -1% | -$28.8K |
|
2571
PUT
Cardinal Health
CAH
$53.2B
| $2.17M | ﹤0.01% |
35,500
+11,800
| +50% | +$730K |
|
2572
Repligen
RGEN
$7.03B
| $2.17M | ﹤0.01% |
59,826
+11,453
| +24% | +$415K |
|
2573
RenaissanceRe
RNR
$13.2B
| $2.17M | ﹤0.01% |
17,278
+1,078
| +7% | +$145K |
|
2574
Under Armour Class C
UA
$2.85B
| $2.17M | ﹤0.01% |
162,554
-44,062
| -21% | -$577K |
|
2575
Dentsply Sirona
XRAY
$2.75B
| $2.16M | ﹤0.01% |
32,822
+1,613
| +5% | +$103K |
|
Similar funds
Citigroup's Q4 2017 Portfolio in Review
As of Q4 2017, Citigroup held 7,845 positions worth $125B, up 2.1% from $122B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Citigroup withdrew a net $3.77B in Q4 2017, closing 246 positions and reducing 2,883 holdings. Its most notable exit was CR Bard Inc., an estimated $210M position sold in full.
By sector, the portfolio is most concentrated in Financials at 4.7% of assets, up from 4.4% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Citigroup opened a new position in Global X US Preferred ETF worth $19.9M.
- Citigroup's largest Q4 2017 buy was Global X US Preferred ETF: 800,000 shares worth $19.9M.
- Citigroup added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2017, an estimated $341M increase.
- Citigroup's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.83B.
- Citigroup fully exited CR Bard Inc. in Q4 2017, selling an estimated $210M.
- Citigroup's ten largest holdings make up 26% of its $125B portfolio in Q4 2017.
- Citigroup opened 463 new positions and closed 246 in Q4 2017.
- Citigroup's portfolio value rose 2.1% quarter-over-quarter to $125B.
Based on Citigroup's 13F filing for Q4 2017, filed 12 Feb 2018.